semaglutide vial injection Sem-P™ - Getz Pharma Weight Loss Injections | Logan

SURPASS studies were conducted to test the effect of another GLP-1 receptor agonisttirzepatidein individuals with DM2

A randomized trial of semaglutide (Ozempic) vs placebo in participants with HIV-associated lipohypertrophy, a pro-inflammatory condition (mean BMI of participants =33 ) was preprint published

We treat people, not just pancreases

If youre unable to eat or drink, experiencing vomiting that lasts more than 24 hours, or losing significant weight unintentionally, reach out to your provider immediately

Patients should not stop taking Ozempic without medical advice but should seek prompt assessment to determine the underlying cause